Advertisement

Eli Lilly and Company LLY

Set alert

Price alert · LLY

All alert types
1,417.54 USD +43.84 +3.19%

At close · Oct 30

1,414.51 -3.03 -0.21%

After hours · Oct 30, 7:59 PM ET

Bid
1,410.64 × 80
Ask
1,416.35 × 120
1,409.00 Day range 1,449.68
844.50 52-week range 1,417.54
YTD
+31.90%
1 year
+67.86%
Open
1,428.83
Prev close
1,373.70
Mkt cap
1.26T
Vol
5.25M
Avg vol
2.52M
EPS
29.79
P/E
47.58
Div yield
0.50%
More statistics
Low
1,409.00
High
1,449.68
Forward P/E
28.70
Beta
0.00
Short ratio
3.00
Inst. own
85.39%
Dividend
6.92
Ex-div date
Nov 12, 2026
Earnings
Feb 3, 2027
50-d avg
1,193.68
200-d avg
1,089.52
1y target
1,377.71

5D chart

Chart tools
Interval

Events in this range
  • Oct 29, 2026Earnings: 7.48; estimate 5.71; surprise 31%
  • Oct 30, 2026Rating: Argus Research · Buy → Buy
  • Oct 30, 2026Rating: RBC Capital · Outperform → Outperform
  • Oct 30, 2026Rating: Truist Securities · Buy → Buy
  • Oct 30, 2026Rating: Wells Fargo · Overweight → Overweight
  • Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Oct 30, 2026Rating: Scotiabank · Sector Outperform → Sector Outperform
Signals (175)
NameTimeAgo
MACD: Buy SignalOct 30, 3:55 PM1 day ago
SMA: BullishOct 30, 3:45 PM1 day ago
SMA: BearishOct 30, 2:40 PM1 day ago
SMA: BearishOct 30, 2:40 PM1 day ago
SMA: BullishOct 30, 2:35 PM1 day ago
SMA: BullishOct 30, 2:30 PM1 day ago
SMA: BearishOct 30, 2:25 PM1 day ago
MACD: Sell SignalOct 30, 2:20 PM1 day ago
SMA: BearishOct 30, 2:15 PM1 day ago
SMA: BullishOct 30, 1:50 PM1 day ago
SMA: BullishOct 30, 1:50 PM1 day ago
MACD: Buy SignalOct 30, 1:50 PM1 day ago
SMA: BearishOct 30, 1:45 PM1 day ago
SMA: BearishOct 30, 1:45 PM1 day ago
MACD: Sell SignalOct 30, 1:45 PM1 day ago
MACD: Buy SignalOct 30, 1:35 PM1 day ago
SMA: BullishOct 30, 1:30 PM1 day ago
SMA: BullishOct 30, 1:20 PM1 day ago
SMA: BearishOct 30, 1:00 PM1 day ago
SMA: BullishOct 30, 12:55 PM1 day ago
SMA: BearishOct 30, 12:50 PM1 day ago
SMA: BullishOct 30, 12:45 PM1 day ago
SMA: BearishOct 30, 12:30 PM1 day ago
SMA: BullishOct 30, 12:15 PM1 day ago
SMA: BearishOct 30, 11:45 AM1 day ago
SMA: BearishOct 30, 11:20 AM1 day ago
RSI: OverboughtOct 30, 11:05 AM1 day ago
SMA: BullishOct 30, 10:40 AM1 day ago
MACD: Sell SignalOct 30, 10:30 AM1 day ago
SMA: BearishOct 30, 10:25 AM1 day ago
SMA: BullishOct 30, 10:20 AM1 day ago
SMA: BearishOct 30, 10:15 AM1 day ago
RSI: OverboughtOct 30, 9:30 AM1 day ago
SMA: BullishOct 29, 3:25 PM2 days ago
SMA: BullishOct 29, 3:25 PM2 days ago
SMA: BearishOct 29, 3:20 PM2 days ago
SMA: BearishOct 29, 3:20 PM2 days ago
SMA: BullishOct 29, 3:10 PM2 days ago
SMA: BullishOct 29, 3:10 PM2 days ago
MACD: Buy SignalOct 29, 3:10 PM2 days ago
SMA: BearishOct 29, 2:40 PM2 days ago
SMA: BullishOct 29, 2:30 PM2 days ago
SMA: BearishOct 29, 2:25 PM2 days ago
SMA: BearishOct 29, 2:10 PM2 days ago
SMA: BullishOct 29, 2:05 PM2 days ago
SMA: BearishOct 29, 2:00 PM2 days ago
SMA: BullishOct 29, 1:55 PM2 days ago
SMA: BullishOct 29, 1:55 PM2 days ago
SMA: BearishOct 29, 1:20 PM2 days ago
SMA: BearishOct 29, 1:20 PM2 days ago
SMA: BullishOct 29, 1:15 PM2 days ago
SMA: BullishOct 29, 1:15 PM2 days ago
SMA: BearishOct 29, 1:10 PM2 days ago
SMA: BullishOct 29, 1:05 PM2 days ago
SMA: BearishOct 29, 1:00 PM2 days ago
SMA: BearishOct 29, 12:55 PM2 days ago
SMA: BullishOct 29, 12:50 PM2 days ago
SMA: BearishOct 29, 12:45 PM2 days ago
SMA: BearishOct 29, 12:45 PM2 days ago
SMA: BullishOct 29, 12:35 PM2 days ago
SMA: BearishOct 29, 12:30 PM2 days ago
SMA: BullishOct 29, 12:20 PM2 days ago
SMA: BullishOct 29, 12:00 PM2 days ago
SMA: BearishOct 29, 11:30 AM2 days ago
SMA: BearishOct 29, 11:20 AM2 days ago
SMA: BullishOct 29, 11:15 AM2 days ago
MACD: Sell SignalOct 29, 10:30 AM2 days ago
SMA: BearishOct 29, 10:15 AM2 days ago
SMA: BullishOct 29, 9:30 AM2 days ago
SMA: BullishOct 29, 9:30 AM2 days ago
MACD: Buy SignalOct 29, 9:30 AM2 days ago
RSI: OverboughtOct 29, 9:30 AM2 days ago
SMA: BearishOct 28, 3:55 PM3 days ago
MACD: Sell SignalOct 28, 3:55 PM3 days ago
SMA: BearishOct 28, 3:50 PM3 days ago
SMA: BullishOct 28, 3:45 PM3 days ago
SMA: BearishOct 28, 3:40 PM3 days ago
MACD: Buy SignalOct 28, 2:40 PM3 days ago
SMA: BullishOct 28, 2:35 PM3 days ago
SMA: BullishOct 28, 2:35 PM3 days ago
MACD: Sell SignalOct 28, 2:25 PM3 days ago
SMA: BearishOct 28, 2:20 PM3 days ago
SMA: BullishOct 28, 2:15 PM3 days ago
SMA: BearishOct 28, 2:10 PM3 days ago
SMA: BearishOct 28, 2:10 PM3 days ago
SMA: BullishOct 28, 2:05 PM3 days ago
SMA: BearishOct 28, 2:00 PM3 days ago
SMA: BullishOct 28, 1:55 PM3 days ago
SMA: BullishOct 28, 1:40 PM3 days ago
SMA: BearishOct 28, 1:30 PM3 days ago
MACD: Buy SignalOct 28, 1:30 PM3 days ago
SMA: BullishOct 28, 1:25 PM3 days ago
SMA: BearishOct 28, 1:20 PM3 days ago
SMA: BullishOct 28, 1:05 PM3 days ago
SMA: BearishOct 28, 1:00 PM3 days ago
SMA: BullishOct 28, 12:55 PM3 days ago
SMA: BearishOct 28, 11:55 AM3 days ago
SMA: BearishOct 28, 11:40 AM3 days ago
SMA: BullishOct 28, 11:15 AM3 days ago
SMA: BearishOct 28, 11:10 AM3 days ago
MACD: Sell SignalOct 28, 11:10 AM3 days ago
RSI: OverboughtOct 28, 10:45 AM3 days ago
SMA: BullishOct 28, 10:30 AM3 days ago
SMA: BearishOct 28, 10:25 AM3 days ago
SMA: BullishOct 28, 9:40 AM3 days ago
SMA: BullishOct 28, 9:40 AM3 days ago
MACD: Buy SignalOct 28, 9:40 AM3 days ago
MACD: Sell SignalOct 28, 9:35 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
SMA: BullishOct 27, 3:35 PM4 days ago
SMA: BullishOct 27, 3:35 PM4 days ago
SMA: BearishOct 27, 3:25 PM4 days ago
SMA: BullishOct 27, 3:00 PM4 days ago
MACD: Buy SignalOct 27, 3:00 PM4 days ago
MACD: Sell SignalOct 27, 2:55 PM4 days ago
SMA: BearishOct 27, 2:40 PM4 days ago
SMA: BullishOct 27, 2:35 PM4 days ago
MACD: Buy SignalOct 27, 2:35 PM4 days ago
MACD: Sell SignalOct 27, 2:25 PM4 days ago
SMA: BearishOct 27, 2:20 PM4 days ago
SMA: BullishOct 27, 2:15 PM4 days ago
MACD: Buy SignalOct 27, 2:15 PM4 days ago
MACD: Sell SignalOct 27, 1:45 PM4 days ago
SMA: BearishOct 27, 1:40 PM4 days ago
SMA: BullishOct 27, 1:35 PM4 days ago
MACD: Buy SignalOct 27, 1:35 PM4 days ago
MACD: Sell SignalOct 27, 1:30 PM4 days ago
SMA: BearishOct 27, 1:20 PM4 days ago
MACD: Buy SignalOct 27, 1:10 PM4 days ago
SMA: BullishOct 27, 1:05 PM4 days ago
SMA: BearishOct 27, 12:45 PM4 days ago
SMA: BullishOct 27, 12:40 PM4 days ago
SMA: BearishOct 27, 11:55 AM4 days ago
SMA: BullishOct 27, 11:50 AM4 days ago
SMA: BearishOct 27, 11:45 AM4 days ago
MACD: Sell SignalOct 27, 11:30 AM4 days ago
SMA: BearishOct 27, 11:25 AM4 days ago
MACD: Buy SignalOct 27, 11:10 AM4 days ago
MACD: Sell SignalOct 27, 11:00 AM4 days ago
MACD: Buy SignalOct 27, 10:40 AM4 days ago
SMA: BullishOct 27, 10:35 AM4 days ago
MACD: Sell SignalOct 27, 10:20 AM4 days ago
SMA: BearishOct 27, 10:15 AM4 days ago
SMA: BullishOct 27, 10:10 AM4 days ago
SMA: BearishOct 27, 10:00 AM4 days ago
RSI: OverboughtOct 27, 9:40 AM4 days ago
SMA: BullishOct 27, 9:35 AM4 days ago
SMA: BullishOct 27, 9:35 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
SMA: BearishOct 26, 3:55 PM5 days ago
SMA: BullishOct 26, 3:50 PM5 days ago
MACD: Buy SignalOct 26, 3:50 PM5 days ago
SMA: BullishOct 26, 3:40 PM5 days ago
SMA: BearishOct 26, 3:05 PM5 days ago
SMA: BearishOct 26, 3:05 PM5 days ago
SMA: BullishOct 26, 3:00 PM5 days ago
SMA: BullishOct 26, 3:00 PM5 days ago
MACD: Sell SignalOct 26, 2:40 PM5 days ago
SMA: BearishOct 26, 2:35 PM5 days ago
SMA: BearishOct 26, 2:35 PM5 days ago
SMA: BullishOct 26, 2:00 PM5 days ago
SMA: BearishOct 26, 1:55 PM5 days ago
SMA: BullishOct 26, 1:15 PM5 days ago
SMA: BullishOct 26, 1:15 PM5 days ago
SMA: BearishOct 26, 1:00 PM5 days ago
SMA: BullishOct 26, 12:50 PM5 days ago
SMA: BearishOct 26, 12:25 PM5 days ago
SMA: BearishOct 26, 12:25 PM5 days ago
SMA: BullishOct 26, 12:15 PM5 days ago
SMA: BullishOct 26, 11:50 AM5 days ago
SMA: BearishOct 26, 11:45 AM5 days ago
SMA: BullishOct 26, 11:40 AM5 days ago
SMA: BearishOct 26, 10:30 AM5 days ago
SMA: BullishOct 26, 10:20 AM5 days ago

Key statistics

Market cap
1.26T
Enterprise value
0
Trailing P/E
47.55
Forward P/E
28.70
PEG ratio
1.32
Price / sales
14.59
Price / book
47.77
EPS (TTM)
29.79
Beta
0.00
Dividend yield
0.50%
Payout ratio
21.69%
Profit margin
31.90%
Revenue (TTM)
86.46B
Revenue growth
38.60%
Free cash flow
0
Total cash
0
Total debt
0
Return on equity
0.00%
Shares outstanding
890.75M
Short % of float
0.78%
50-day average
1,193.68
200-day average
1,089.52

Analyst view

Consensus: buy

Buy
Price target (mean) 1,377.71 -2.8% downside
Target (low)
930.00
Target (mean)
1,377.71
Target (high)
1,650.00
Ratings (0m) 31 26 buy · 3 hold · 2 sell
  • Strong buy6
  • Buy20
  • Hold3
  • Sell1
  • Strong sell1

Next earnings

Feb 3, 2027

Expected Feb 3, 2027. Consensus EPS estimate 11.12.

Earnings history

Financials — quick view

All financials
LLY Revenue — quarterly 24.40B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
LLY Net income — quarterly 6.45B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
LLY EPS — quarterly 7.23
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

LLY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 3, 2027Dec 30, 202610.46———
Oct 29, 2026Sep 30, 20265.717.48+1.77+31.00%
Aug 5, 2026Jun 30, 20266.408.38+1.98+30.94%
Apr 30, 2026Mar 31, 20266.978.55+1.58+22.67%
Feb 4, 2026Dec 31, 20256.917.54+0.63+9.12%
Oct 30, 2025Sep 30, 20255.697.02+1.33+23.37%

Upgrades / downgrades

LLY analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026ScotiabankmainSector OutperformSector Outperform
Oct 30, 2026Morgan StanleymainOverweightOverweight
Oct 30, 2026Wells FargomainOverweightOverweight
Oct 30, 2026Truist SecuritiesreitBuyBuy
Oct 30, 2026RBC CapitalmainOutperformOutperform
Oct 30, 2026Argus ResearchmainBuyBuy

About Eli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss; Olumiant; Omvoh; and Taltz. Further, it provides Emgality for migraine prevention and episodic cluster headache; and Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; BioArctic AB (publ) for new treatment; QurCan Therapeutics Inc for development of PLNP-enabled genetic medicine therapeutics for the treatment of central nervous system and peripheral nervous system; and Abbisko Therapeutics for discovery and development of medicines across multiple targets. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
Website
lilly.com

News

Your note

Sign in to keep a note on LLY — it syncs with the Stock Master app.

Insider holders

LLY insider holders
InsiderRelationLatest transactionDateShares held
ALVAREZ RALPHDirectorStock Award(Grant)Oct 18, 202656,606
FYRWALD J. ERIKDirectorStock Award(Grant)Oct 18, 202675,544
HAKIM ANATGeneral CounselSaleAug 6, 20260
HERNANDEZ EDGARDOOfficerStock GiftSep 1, 202646,956
JONSSON PATRIKOfficerSaleAug 16, 202654,779
LILLY ENDOWMENT, INC.Beneficial Owner of more than 10% of a Class of SecuritySaleMay 5, 202691,881,200

Institution ownership

LLY institution ownership
Holder% heldSharesValueReported
Lilly Endowment, Inc9.57%90,066,978127.58BSep 29, 2026
Blackrock Inc.7.17%67,540,40095.67BJun 29, 2026
Vanguard Capital Management LLC5.69%53,528,86875.83BJun 29, 2026
PNC Financial Services Group, Inc.5.45%51,322,72072.70BJun 29, 2026
State Street Corporation3.85%36,215,75451.30BJun 29, 2026
FMR, LLC3.02%28,462,47540.32BJun 29, 2026

Fund ownership

LLY fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.86%26,907,51238.12BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.18%20,499,29729.04BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.13%10,662,00915.10BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.09%10,268,70414.55BAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.05%9,899,46814.02BSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Growth Index Fund0.94%8,873,90012.57BJun 29, 2026
Advertisement